New FDA-Approved COVID Pill: XOCOVA Reduced Symptomatic COVID Significantly | Expert Interview

In this episode

A new FDA-approved oral antiviral may offer a new option for people exposed to COVID-19.In this episode 161 of the DoctorPodcasts Show, Dr. Robert Cykiert interviews two physicians from the Shionogi Pharmaceutical Company who discuss XOCOVA®, its recent FDA approval, how it works, who may be eligible, and the clinical trial results behind the approval.Joining us are:Florin Draica, MD — Head of U.S. Medical Affairs at Shionogi Pharmaceutical CompanySimon Portsmouth, MD — Senior Vice President and Head of Clinical Development at Shionogi Pharmaceutical CompanyIn this interview, we discuss:• Why COVID-19 is still a health concern in 2026• What happens after you are exposed to SARS-CoV-2• What is XOCOVA?• How does this new COVID antiviral work?• What is a main protease inhibitor?• How is XOCOVA different from previous COVID treatments?• Is XOCOVA for people who already have COVID—or people exposed to someone with COVID?• What did the Phase 3 SCORPIO-PEP clinical trial find?• Why did the study report a 67% reduction in symptomatic COVID-19 through Day 10 in its primary analysis?• How did XOCOVA perform among people with risk factors for severe COVID?• Does XOCOVA replace COVID vaccination?• How soon after COVID exposure should someone contact a healthcare professional?• What are the potential side effects and medication interactions?• Who should and should not take XOCOVA?• Why pregnant or breastfeeding patients should discuss alternatives with their healthcare professional• Could main protease inhibitor technology help prepare us for future coronavirus outbreaks or pandemics?The discussion emphasizes that XOCOVA is intended for people who have been exposed to COVID-19 and are not yet sick, and that treatment decisions should be made with a qualified healthcare professional. The interview discusses taking action promptly after exposure, including the timeframe discussed by the guests.The guests also explain why XOCOVA is not intended to replace vaccination, but may provide another approach following exposure to COVID-19.Subscribe to DoctorPodcasts for interviews with leading physicians, scientists, researchers, and experts discussing the latest developments in medicine, health, science, technology, and public health.👍 If you found this interview informative, please LIKE the video, SUBSCRIBE, and turn on notifications for future interviews.Important medical disclaimerThis video is for educational and informational purposes only and is not individual medical advice. XOCOVA is a prescription medication. Whether it is appropriate for a particular person depends on individual circumstances, medical history, medications, and other factors. Please consult a qualified healthcare professional regarding diagnosis and treatment decisions.#XOCOVA #Ensitrelvir #COVID19 #COVID #COVIDPrevention #Antiviral #FDAApproved #Coronavirus #SARSCoV2 #COVIDTreatment #PublicHealth #MedicalPodcast #Healthcare #DrPodcast #Shionogi